As our nation nears the frightening fiscal cliff, funding for ophthalmology residency training is unlikely to increase at the rate necessary to meet the projected demand. According to Dr. Peter J. McDonnell at Wilmer Eye Institute in a December 2012
When world-renowned clinician scientist Edwin Stone MD, PhD at the University of Iowa asked a group of applicants to the ophthalmology residency program for questions, I curiously asked, “Which of your many research efforts are you most excited about?” Dr.
So often as physicians and patients we become frustrated at seemingly ridiculous prices for medications that likely are produced for a fraction of the cost. We view pharmaceutical companies as tyrannical price-gougers that profit from patients, and from patents, at
As part of the ARVO 2012 Entrepreneurship in Ophthalmology symposium, we at eyesteve.com were impressed with start-up Oculeve for its innovative solution to dry eye disease. Estimated to affect more than 20 million Americans, with 1.6 million having the most
Published in this week’s Nature Photonics, researchers at Stanford University have taken the next innovative step in treating retinal disease with a wire-free, battery-free bionic eye. Several forms of retinal implants have been in development for over a year, but
ARVO Day #1 – Saturday From identifying unmet needs and product concept to intellectual property and commercialization, today’s ARVO education course provided invaluable information to entrepreneurs hoping to have their idea become extremely $$$valuable$$$. The morning presentations provided the basic
Above is the poster that eyesteve.com founder, Steve Christiansen, presented at ARVO 2012 in Ft. Lauderdale, Florida. This project describes a retrospective analysis of 3337 eyes who underwent LASIK or PRK, and analyzes the ratio of change in keratometry (ΔK) to